Cargando…
A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines
BACKGROUND: In 2001, two hexavalent vaccines were licensed in Italy (Hexavac(®), Infanrix Hexa(®)), and since 2002 were extensively used for primary immunization in the first year of life (at 3, 5, 11/12 months of age). In 2005, the market authorization of Hexavac(® )was precautionary suspended by E...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527316/ https://www.ncbi.nlm.nih.gov/pubmed/18662386 http://dx.doi.org/10.1186/1471-2334-8-100 |